CTRI/2023/02/049401RecruitingPhase 4
A double blind, randomized, placebo controlled clinical study to Evaluate the efficacy of Cannasen Nasal spray Night in patients with insomnia
Cannordic A/S0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Pms
Eligibility Criteria
Inclusion Criteria
- •1. Patient from 18 to 65 years of age.
- •2. Patient with the history of seasonal pollen allergy.
- •3. If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.
- •4. Patient that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
- •5. Patient willing to avoid participation in any other interventional clinical trial for the duration of the study.
Exclusion Criteria
- •1. Females that are pregnant, breast feeding, or planning to get pregnant during the study.
- •2. Patient that have participated in any other interventional clinical trial in the previous 30 days.
- •3. Patient with known sensitivity to any of the constituents of the investigational product.
- •4. Patient that are taking applying other product.
Investigators
Similar Trials
Completed
Phase 3
A clinical trial to study the effectiveness and safety of Lanreotide injection in patients with carcinoid syndrome. Carcinoid syndrome is a group of symptoms associated with carcinoid tumors,such as diarrhea and/or flushing.CTRI/2011/04/001690Ipsen Pharma SAS100
Completed
Not Applicable
A clinical study to assess effect of an herbal product in improving testosterone levels in healthy young malesCTRI/2018/11/016337aila Nutraceuticals120
Completed
Not Applicable
Effect of LN22197 in healthy subjects with sleep disturbance due to mild to moderate musculoskeletal discomfortCTRI/2022/09/045855aila Nutraceuticals60
Completed
Not Applicable
Clinical trial to evaluate the efficacy and safety of investigational product (MXP22) on liver health.CTRI/2022/06/043558Synergia Life Sciences Pvt Ltd59
Active, not recruiting
Not Applicable
A clinical study to evaluate the safety and efficacy of a food supplement in improving skin healthCTRI/2022/11/047326aturetech Co., Ltd.